Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 2, 2000

View Archived Issues

Evotec Lands Oxford Asymmetry In EUR484.7M Stock Deal

Lean Gene Discovery Could Lead To Therapy For Obesity/Diabetes

EuropaBio Threads Its Way Through Gene Therapy Debate

GroPep Eyes Raising $10.4M In IPO To Move Treatments Along

Circassia Receives Seed Funding To Focus On Pet-Caused Allergies

Science Foundation Ireland Seeks Research Proposals In Biotech, IT

Israeli Biotech Gets Boost From Government Status Designation

Antisoma Raises #8.7M, Aims To Double Clinical Programs

Another EU Body Urges Caution On GMO Risks

Pharmagene Obtains LSE Listing, Raises $55.5M In Initial Offering

Harmonization Group Will Look At Gene Therapy In November

Dropoff In R&D Spending Helps

TranXenogen Stock On The Ascent

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.